Unituxin
Payments companies reported to CMS as associated with Unituxin. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Unituxin, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Unituxin
These are the largest totals companies reported as associated with Unituxin. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Araz Marachelian | Los Angeles, CA | Pediatric Hematology-Oncology | $741.69 |
| Michael Migotsky | Los Angeles, CA | $525.84 | |
| Brittany Frazer | Los Angeles, CA | Pediatrics (Nurse Practitioner) | $376.73 |
| Sara-Jane Onyeama | Loma Linda, CA | $242.66 | |
| Mariel Martinez | Wilmette, IL | Pediatrics (Nurse Practitioner) | $165.73 |
| Lizza Hernandez | San Antonio, TX | Pediatrics (Nurse Practitioner) | $159.37 |
| Leonora Slatnick | Aurora, CO | Pediatric Hematology-Oncology | $152.00 |
| Casey Mehrhoff | Maywood, IL | Pediatric Hematology-Oncology | $151.99 |
| Christopher Kuo | Los Angeles, CA | $147.84 | |
| Elizabeth Eisenman | Memphis, TN | Family | $129.75 |
Prescribed Unituxin?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.